1
|
Dalkıran B, Beydoğan B, Erdemir AG, Düzgün SA, Gümeler E, İdilman IS, Onur MR, Akpınar E. Imaging findings of traumatic injuries in survivors of the 6 February 2023 earthquake in Turkey. Clin Radiol 2024; 79:19-24. [PMID: 37863746 DOI: 10.1016/j.crad.2023.09.018] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/26/2023] [Revised: 09/13/2023] [Accepted: 09/23/2023] [Indexed: 10/22/2023]
Abstract
In the southeastern part of Turkey, two earthquakes measuring 7.7 and 7.8 on the Richter scale occurred within 9 h on 6 February 2023, causing 120,000 injuries and over 50,000 deaths. Evacuees were transferred to various secondary and tertiary hospitals as the health system and hospitals in the affected region were affected by the earthquake. Injuries were mostly caused by blunt trauma and/or prolonged bruising under rubble. The severity and pattern of traumatic injuries in earthquake victims differed from other trauma patients who were not affected by an earthquake. In addition to traumatic injuries that affected multiple body regions and systems, patients who were trapped under debris for long periods of time were also frequently found to have crush syndrome. Pulmonary thromboembolism and hypoxic-ischaemic brain injury were observed in some patients. In this review, we present the imaging findings of traumatic injuries in earthquake victims, emphasising the earthquake-related distinct injury types.
Collapse
Affiliation(s)
- B Dalkıran
- Department of Radiology, Faculty of Medicine, Hacettepe University, 06100, Ankara, Turkey
| | - B Beydoğan
- Department of Radiology, Faculty of Medicine, Hacettepe University, 06100, Ankara, Turkey
| | - A G Erdemir
- Department of Radiology, Faculty of Medicine, Hacettepe University, 06100, Ankara, Turkey
| | - S A Düzgün
- Department of Radiology, Faculty of Medicine, Hacettepe University, 06100, Ankara, Turkey
| | - E Gümeler
- Department of Radiology, Faculty of Medicine, Hacettepe University, 06100, Ankara, Turkey
| | - I S İdilman
- Department of Radiology, Faculty of Medicine, Hacettepe University, 06100, Ankara, Turkey
| | - M R Onur
- Department of Radiology, Faculty of Medicine, Hacettepe University, 06100, Ankara, Turkey.
| | - E Akpınar
- Department of Radiology, Faculty of Medicine, Hacettepe University, 06100, Ankara, Turkey
| |
Collapse
|
2
|
Günay S, Parlak IS, Hezer H, Şeref Parlak EŞ, Umut MS, Hancıoğlu Z, Çelenk Ergüden H, Kocaman Y, Dalkıran A, Sertçelik Ü, Şerifoğlu İ, Akpınar E, Göktaş MF, Fidan M, Babahanoğlu B, Cander FS, Çıvgın E, Er M, Kılıç H, Argüder E, Tuğ T, Ünsal E, Hasanoğlu C, Günay İ, Babayiğit M, Ağca B, Karalezli A. Risk factors for the development of interstitial lung disease following severe COVID-19 pneumonia and outcomes of systemic corticosteroid therapy: 3-month follow-up. Sarcoidosis Vasc Diffuse Lung Dis 2023; 40:e2023029. [PMID: 37712369 PMCID: PMC10540725 DOI: 10.36141/svdld.v40i3.14418] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Received: 03/08/2023] [Accepted: 08/01/2023] [Indexed: 09/16/2023]
Abstract
BACKGROUND We aimed to evaluate the pulmonary involvement status, its related factors, and pulmonary function test (PFT) results in the first month follow-up in patients who were discharged for severe Covid-19 pneumonia, and to assess the efficacy of corticosteroid treatment on these parameters in severe pulmonary involvement patients. METHODS We retrospectively analyzed all consecutive patients who applied to our COVID-19 follow-up clinic at the end of the first month of hospital discharge. Functional and radiological differences were compared after 3 months of corticosteroid treatment in severe pulmonary involvement group. Results We analyzed 391 patients with "pulmonary parenchymal involvement" (PPIG) and 162 patients with "normal lung radiology" (NLRG). 122 patients in the PPIG (corticosteroid-required interstitial lung disease group (CRILD)) had severe pulmonary involvement with frequent symptoms and required corticosteroid prescription. Pulmonary involvement was more common in males and elder patients (P<0.001, for both). Being smoker and elderly were associated with a higher risk-ratio in predicting to be in PPIG (OR:2.250 and OR:1.057, respectively). Smokers, male and elderly patients, and HFNO2 support during hospitalization were risk factors for being a patient with CRILD (OR:2.737, OR:4.937, OR:4.756, and OR:2.872, respectively). After a three-months of methylprednisolone medication, a good response was achieved on radiological findings and PFT results in CRILD. CONCLUSIONS In conclusion, after severe COVID-19 pneumonia, persistent clinical symptoms and pulmonary parenchymal involvement would be inevitable in elder and smoker patients. Moreover, corticosteroid treatment in patients with severe parenchymal involvement was found to be effective in the improvement of radiological and functional parameters.
Collapse
Affiliation(s)
- Sibel Günay
- Department of Pulmonary Diseases, Ankara Bilkent City Hospital, Ankara, Turkiye .
| | | | - Habibe Hezer
- Department of Pulmonary Diseases, Ankara Bilkent City Hospital, Ankara, Turkiye .
| | | | - Melike Sanem Umut
- Department of Pulmonary Diseases, Ankara Bilkent City Hospital, Ankara, Turkiye .
| | - Zeynep Hancıoğlu
- Department of Pulmonary Diseases, Ankara Bilkent City Hospital, Ankara, Turkiye .
| | - Hülya Çelenk Ergüden
- Department of Pulmonary Diseases, Ankara Bilkent City Hospital, Ankara, Turkiye .
| | - Yasin Kocaman
- Department of Pulmonary Diseases, Ankara Bilkent City Hospital, Ankara, Turkiye .
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
3
|
Kilic H, Arguder E, Karalezli A, Unsal E, Guner R, Kayaslan B, Hasanoglu İ, Ates İ, Civak M, Akpınar E, Parlak E, Sadi F, Kocaman Y, Günay S, Metan E, Er M, Dalkıran A, Hezer H, Ergüden H, Hancıoğlu Z, Kalem A, Eser F, Aypak A, Akıncı E, Karahmetoğlu S, Gemcioglu E, Kalkan E, İnan O, Yilmaz A, Güler B, Çopuroğlu E, Turan İ, Gökmen D, Hayme S, Surel AA. Effect of chronic lung diseases on mortality of prevariant COVID-19 pneumonia patients. Front Med (Lausanne) 2022; 9:957598. [PMID: 36314036 PMCID: PMC9606396 DOI: 10.3389/fmed.2022.957598] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/31/2022] [Accepted: 09/20/2022] [Indexed: 11/26/2022] Open
Abstract
Background The aim of the study is to assess the effect of chronic lung disease on mortality in patients hospitalized with the diagnosis of prevariant COVID-19 Pneumonia compared to patients without chronic lung disease. Research design and methods A cohort of 1,549 patients admitted to the pandemic clinic with a COVID-19 Pneumonia diagnosis was analyzed. Group 1 and Group 2 were compared in terms of the treatment they received, admission to intensive care, mortality and follow-up parameters. Results The patient group with COVID-19 and lung disease consisted of 231 participants (14.91%) (Group 1). The patient group with COVID-19 but without lung disease had 1,318 participants (85.19%). Group 1 cases were found to receive more oxygen therapy and mechanical ventilation than Group 2 cases (p ≤ 0.001), Following univariate and multiple logistic regression analyses, it was determined that patients with chronic lung disease had a 25.76% higher mortality risk [OR: 25.763, 95% CI (Lower-Upper) (2.445–271.465), p = 0.007]. Conclusion It was found that chronic lung disease contributed significantly to mortality in this study. Among chronic lung diseases, Chronic Obstructive Pulmonary Disease (COPD), lung cancer and interstitial lung diseases (ILDs) were shown to be more effective than other chronic lung diseases in patients with prevariant COVİD-19 population.
Collapse
Affiliation(s)
- Hatice Kilic
- Department of Pulmonary Medicine, Faculty of Medicine, Ankara Yildirim Beyazit University, Ankara, Turkey,*Correspondence: Hatice Kilic,
| | - Emine Arguder
- Department of Pulmonary Medicine, Faculty of Medicine, Ankara Yildirim Beyazit University, Ankara, Turkey
| | - Aysegul Karalezli
- Department of Pulmonary Medicine, Faculty of Medicine, Ankara Yildirim Beyazit University, Ankara, Turkey
| | - Ebru Unsal
- Department of Pulmonary Medicine, Faculty of Medicine, Ankara Yildirim Beyazit University, Ankara, Turkey
| | - Rahmet Guner
- Department of Infectious Disease, Faculty of Medicine, Ankara Yildirim Beyazit University, Ankara, Turkey
| | - Bircan Kayaslan
- Department of Infectious Disease, Faculty of Medicine, Ankara Yildirim Beyazit University, Ankara, Turkey
| | - İmran Hasanoglu
- Department of Infectious Disease, Faculty of Medicine, Ankara Yildirim Beyazit University, Ankara, Turkey
| | - İhsan Ates
- Department of Internal Medicine Disease, Faculty of Medicine, Ankara University of Health Science, Ankara City Hospital, Ankara, Turkey
| | - Musa Civak
- Department of Internal Medicine Diseases, Ankara City Hospital, Ankara, Turkey
| | - Esmehan Akpınar
- Department of Chest Diseases, Ankara City Hospital, Ankara, Turkey
| | - Ebru Parlak
- Department of Chest Diseases, Ankara City Hospital, Ankara, Turkey
| | - Filiz Sadi
- Department of Chest Diseases, Ankara City Hospital, Ankara, Turkey
| | - Yasin Kocaman
- Department of Chest Diseases, Ankara City Hospital, Ankara, Turkey
| | - Sibel Günay
- Department of Chest Diseases, Ankara City Hospital, Ankara, Turkey
| | - Esra Metan
- Department of Chest Diseases, Ankara City Hospital, Ankara, Turkey
| | - Mukremin Er
- Department of Chest Diseases, Ankara City Hospital, Ankara, Turkey
| | - Aynil Dalkıran
- Department of Chest Diseases, Ankara City Hospital, Ankara, Turkey
| | - Habibe Hezer
- Department of Chest Diseases, Ankara City Hospital, Ankara, Turkey
| | - Hülya Ergüden
- Department of Chest Diseases, Ankara City Hospital, Ankara, Turkey
| | - Zeynep Hancıoğlu
- Department of Chest Diseases, Ankara City Hospital, Ankara, Turkey
| | - Ayşe Kalem
- Department of Infectious Disease, Faculty of Medicine, Ankara Yildirim Beyazit University, Ankara, Turkey
| | - Fatma Eser
- Department of Infectious Disease, Faculty of Medicine, Ankara Yildirim Beyazit University, Ankara, Turkey
| | - Adalet Aypak
- Department of Infectious Disease, Faculty of Medicine, University of Health Science, Ankara, Turkey
| | - Esragül Akıncı
- Department of Infectious Disease, Faculty of Medicine, University of Health Science, Ankara, Turkey
| | - Selma Karahmetoğlu
- Department of Internal Medicine Diseases, Ankara City Hospital, Ankara, Turkey
| | - Emin Gemcioglu
- Department of Internal Medicine Diseases, Ankara City Hospital, Ankara, Turkey
| | - Emra Kalkan
- Department of Internal Medicine Diseases, Ankara City Hospital, Ankara, Turkey
| | - Osman İnan
- Department of Internal Medicine Diseases, Ankara City Hospital, Ankara, Turkey
| | - Abdulrezzak Yilmaz
- Department of Internal Medicine Diseases, Ankara City Hospital, Ankara, Turkey
| | - Bagdagul Güler
- Department of Internal Medicine Diseases, Ankara City Hospital, Ankara, Turkey
| | - Esra Çopuroğlu
- Department of Internal Medicine Diseases, Ankara City Hospital, Ankara, Turkey
| | - İşil Turan
- Department of Anesthesia, Ankara City Hospital, Ankara, Turkey
| | - Derya Gökmen
- Department of Biostatistics, School of Medicine, Ankara University, Ankara, Turkey
| | - Serhat Hayme
- Department of Biostatistics, School of Medicine, Ankara University, Ankara, Turkey
| | - Aziz Ahmet Surel
- Department of General Surgery, Ankara City Hospital, Ankara, Turkey
| |
Collapse
|